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Abstract
Narcolepsy patients often suffer from insomnia in addition to excessive daytime sleepiness. Narcoleptic animals also show
behavioral instability characterized by frequent transitions between all vigilance states, exhibiting very short bouts of NREM
sleep as well as wakefulness. The instability of wakefulness states in narcolepsy is thought to be due to deficiency of orexins,
neuropeptides produced in the lateral hypothalamic neurons, which play a highly important role in maintaining
wakefulness. However, the mechanism responsible for sleep instability in this disorder remains to be elucidated. Because
firing of orexin neurons ceases during sleep in healthy animals, deficiency of orexins does not explain the abnormality of
sleep. We hypothesized that chronic compensatory changes in the neurophysiologica activity of the locus coeruleus (LC)
and dorsal raphe (DR) nucleus in response to the progressive loss of endogenous orexin tone underlie the pathological
regulation of sleep/wake states. To evaluate this hypothesis, we examined firing patterns of serotonergic (5-HT) neurons
and noradrenergic (NA) neurons in the brain stem, two important neuronal populations in the regulation of sleep/
wakefulness states. We recorded single-unit activities of 5-HT neurons and NA neurons in the DR nucleus and LC of orexin
neuron-ablated narcoleptic mice. We found that while the firing pattern of 5-HT neurons in narcoleptic mice was similar to
that in wildtype mice, that of NA neurons was significantly different from that in wildtype mice. In narcoleptic mice, NA
neurons showed a higher firing frequency during both wakefulness and NREM sleep as compared with wildtype mice. In
vitro patch-clamp study of NA neurons of narcoleptic mice suggested a functional decrease of GABAergic input to these
neurons. These alterations might play roles in the sleep abnormality in narcolepsy.
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Introduction
Orexin A and orexin B (hypocretin 1 and hypocretin 2) are
hypothalamic neuropeptides implicated in the regulation of sleep/
wakefulness states [1,2].
Orexin neurons diffusely innervate the entire neuroaxis
excluding the cerebellum, with particularly dense innervation to
monoaminergic/cholinergic nuclei in the brain stem, such as the
raphe nuclei, tuberomammillary nucleus (TMN), locus coeruleus
(LC), and laterodorsal/pedunculopontine tegmental nuclei (LDT/
PPT) [3,4]. These nuclei are thought to play important roles in
sleep/wakefulness regulation.
The role of these monoaminergic/cholinergic neurons in sleep/
wakefulness regulation has been clarified by the correlation of their
spontaneous firing frequency with the sleep-waking cycle [5–10].
Monoaminergic release in several cortical and subcortical sites was
also correlated with the sleep-waking cycle [11–17].
Several lines of evidence have suggested that orexins maintain
wakefulness by regulating these monoaminergic neurons. Firstly,
two orexin receptors are differentially expressed in these nuclei
[18,19]. Secondly, electrophysiological studies showed that orexins
excite these monoaminergic neurons [20–22]. Thirdly, the change
in firing rate of orexin neurons showed a similar pattern to that of
monoaminegic neurons [23–25], with rapid firing during wake-
fulness and attenuation of firing during sleep.
Selective loss of orexin neurons causes the sleep disorder,
narcolepsy, in humans and animals. Although the cardinal
symptom of human narcolepsy is severe excessive daytime
sleepiness, patients also frequently suffer from insomnia with
premature nocturnal awakening. Orexin-deficient mice also show
short bouts of both NREM sleep and wakefulness. These mice
have more transitions between all states [26]. Abnormality of
NREM sleep cannot be simply explained by orexin deficiency,
because orexin neurons cease firing during sleep [23–25].
Therefore, we hypothesized that chronic compensatory changes
in the function of wake-promoting regions might affect NREM
sleep in narcolepsy.
In this study, we examined whether the activity of monoam-
inergic neurons is changed in narcolepsy model mice, in relation to
their activities during sleep/wakefulness states. Although 5-HT
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neurons showed almost normal firing patterns according to
behavioral states, NA neurons in the LC showed an altered firing
pattern. NA neurons in orexin/ataxin-3 mice showed higher activity
as compared with those in wildtype mice during both wakefulness
and NREM sleep, especially in the early epoch of NREM sleep.
We also found that the frequencies of sIPSCs and mIPSCs of NA
neurons were markedly decreased in orexin/ataxin-3 mice as
compared with wildtype mice, suggesting that the increase in
firing rate of NA neurons might be due to alterations in
GABAergic input to these cells.
Results
Characteristics of Sleep States of Orexin/Ataxin-3 Mice
Under Recording Condition
To record single-unit activities of neurons extracellularly in a
non-anesthetized mouse, we restrained the mouse in a stereotaxic
frame with a plastic plate attached to its skull. To examine the
effect of this restrained condition on the sleep/wakefulness cycle,
orexin/ataxin-3 mice and their wildtype littermates were analyzed
by simultaneous EEG/EMG recording. We found that the sleep/
wakefulness characteristics of orexin/ataxin-3 mice were comparable
to those of wildtype mice under this recording condition in the late
light period (from 13:00 to 18:00). The percentage of the total of
each episode time was similar in both groups (W, 19.662.6 vs
24.764.3%; NREM sleep, 59.862.6 vs 55.461.0%; REM sleep,
20.062.2 vs 18.763.3%; quiet waking (qW), 0.560.4 vs
1.164.5%, wildtype mice vs orexin/ataxin-3 mice, t7 = 0.74
p= 0.37, t4 = 1.68 p= 0.2, t7 = 0.30 p= 0.77, t7 = 0.97 p= 0.36,
respectively). The mean episode durations in orexin/ataxin-3 mice
also did not show a significant difference to those in wildtype mice
(W, 16.161.4 vs 17.061.0 s; NREM sleep, 49.166.5 vs 39.866.6
s; REM sleep, 91.8612.5 vs 95.6610.2 s; qW 5.963.4 vs
10.362.1 s, wildtype mice vs orexin/ataxin-3 mice,
t7 = 0.54 p= 0.60, t7 = 0.99 p= 0.35, t7 = 0.24 p= 0.81,
t7 = 1.14 p= 0.29, respectively). There was no significant differ-
ence in REM sleep latency between genotypes (65.464.5 vs
59.164.2 s, wildtype mice vs orexin/ataxin-3 mice,
t7 = 1.02 p= 0.34, respectively). Episode number per unit time in
orexin/ataxin-3 mice was not significantly different from that in
wildtype mice (n = 10, t7 = 1.06 p= 0.32). EEG/EMG recording
showed no direct transition from the awake state to REM sleep
during the recording time, consistent with a previous report
showing that nearly all episodes of cataplexy occurred during the
dark period [26,27].
In our previous report, in a freely moving condition, the
percentages of wakefulness and NREM sleep time were almost the
same in wildtype and orexin/ataxin-3 mice. This result was
reproduced in a head-restrained condition. Although the total
time of REM sleep in the light period was shorter in orexin/ataxin-3
mice than in wildtype mice in a freely moving condition [27], there
was no significant difference between the two genotypes in a head-
restrained condition. However, in the head-restrained condition,
we observed a relatively longer REM sleep time as compared to
that in a freely behaving condition. We also observed a
considerably shorter length of NREM sleep (39–49 s). These
might possibly be due to the restraint stress. We analyzed the total
gathered sleep time data obtained from the mice in which
extracellular recordings were successfully obtained. Recordings
were lost mainly when mice were in active wakefulness. These
conditions made the amount of REM sleep longer in our recording
condition than in a normal freely behaving condition.
We also examined whether head-restrained stress equally
affected orexin/ataxin-3 and wildtype mice. Corticotropin releasing
factor mRNA and serum corticosterone levels in a restrained
condition showed no significant difference between these two
genotypes (1.8060.40 vs 1.2460.08, 237.5654.9 vs 389.0645.1,
wildtype mice vs orexin/ataxin-3 mice, t8 = 1.34 p= 0.22,
t9 = 2.07 p= 0.07, respectively). This result suggests that our
recording condition evoked similar physiological stress in orexin/
ataxin-3 and wildtype mice.
Firing of Serotonergic Neurons in Wildtype Mice
Similarly to in rats, mouse 5-HT neurons were identified by
their typical broad spike. In addition, the broad-spike neurons
were characterized by their negative component, with a slowly
decaying slope being much smaller in amplitude than the positive
component and a shoulder on the descending phase of action
potentials (Fig. 1A). Histological evaluation validated that the
recorded neurons were all located within the area corresponding
to the DR (Fig. 1B). Neurons were recorded for 3 to 20 min, and
were typically lost during large movements associated with periods
of active wakefulness.
Recorded neurons showed changes in spontaneous firing
frequency that correlated with the sleep/wakefulness cycle
(Fig. 1C). During wakefulness, mean firing frequency was
2.9660.57 Hz (n= 19). During NREM sleep, these cells showed
a decrease in firing frequency to 0.6860.12 Hz (n= 21). During
REM sleep, they nearly ceased firing (0.0660.05 Hz, n= 14)
(Fig. 1E). Coefficient of variation (C.V.) of the spike interval of W,
NREM sleep and REM sleep was 0.6460.05 (n= 19), 0.9060.13
(n= 21) and 0.2660.20 (n= 14), respectively.
Firing of Serotonergic Neurons in Orexin/Ataxin-3 Mice
A total of 24 5-HT neurons in the DR of orexin/ataxin-3 mice
were recorded. The overall firing patterns of 5-HT neurons in
orexin/ataxin-3 mice across the sleep-wakefulness cycle are
illustrated in Fig. 1D. Mean firing rates of 5-HT neurons in
orexin/ataxin-3 were 2.8060.47 Hz (n = 18) during W,
0.9860.18 Hz (n= 23) during NREM sleep, and 0.0560.02 Hz
(n= 14) during REM sleep (Fig. 1E).
The firing frequency in NREM sleep in orexin/ataxin-3 mice
tended to be higher but the difference did not reach significance
(0.9860.18 and 0.6860.12 Hz, respectively, t42 = 1.37 p= 0.17).
Mean firing frequency during W and REM sleep also showed no
significant difference. C.V. of the spike interval in W, NREM sleep
and REM sleep was 0.5960.05 (n= 18), 1.1260.16 (n= 23), and
0.5360.26 (n= 14). Again, there was no significant difference in
this parameter between orexin/ataxin-3 mice and wildtype mice
(t35 = 0.62 p= 0.54, t42 = 1.06 p= 0.29, t26 = 0.81 p= 0.43,
respectively). These observations suggest that 5-HT neurons in
orexin/ataxin-3 mice have almost normal firing frequency and
normal firing patterns in all sleep/wakefulness states, consistent
with a previous report showing that the discharge patterns of
serotonergic dorsal raphe cells of narcoleptic dogs across sleep-
waking states did not differ from those recorded in normal
animals, with tonic discharge in waking, reduced activity in non-
REM sleep and cessation of activity in REM sleep [28].
Firing of Noradrenergic Neurons in Wildtype Mice
NA neurons were identified mainly by their typical broad action
potentials, with a spike shape similar to that of 5-HT neurons.
Spontaneous firing frequency during the sleep-waking cycle was
used only as a guide (Fig. 2A, C). Histological examination
performed by marking the recording position after recording
validated that the recording area corresponded to the LC (Fig. 2B).
Their mean firing frequency was 1.0060.26 Hz (n= 9) during W.
During NREM sleep, most NA neurons ceased firing 1 to 2
Monoaminergic Neurons in Narcoleptic Mice
PLOS ONE | www.plosone.org 2 July 2013 | Volume 8 | Issue 7 | e70012
seconds prior to the onset of EEG synchronization (firing
frequency was 0.0760.05 Hz, n= 19). Firing of NA neurons
abruptly ceased at the boundaries of W and NREM sleep. This
pattern is distinct from the firing pattern of 5-HT neurons, which
showed a gradual decrease of firing during NREM sleep (Fig. 2E).
This suggests that the firing pattern of NA neurons is more tightly
regulated according to vigilance states as compared with 5-HT
neurons.
During REM sleep, they were completely silent (firing
frequency was 0 Hz, n= 9). C.V. of the spike interval of W,
NREM sleep and REM sleep was 0.9460.10 (n= 9), 0.1860.08
(n = 19) and 0 (n= 9), respectively.
Firing of NA Neurons in Orexin/Ataxin-3 Mice
The overall mean firing rates of NA neurons in orexin/ataxin-3
mice were significantly higher than those in wildtype mice during
W (1.8760.27 Hz, n= 11, t18 = 2.37 p= 0.029) and NREM sleep
(0.2360.05 Hz, n= 19, t36 = 2.18 p= 0.036) (Fig. 2E). Firing
frequency of NA neurons in orexin/ataxin-3 mice during REM sleep
(0.0160.01 Hz, n= 7) was similar to that in wildtype mice
(Fig. 2E). C.V. of the spike interval during W, NREM sleep and
REM sleep was 0.7060.04 (n= 11), 0.7560.15 (n= 19), and
0.1060.10 (n = 7), respectively. C.V. during W was significantly
smaller than that in wildtype (t18 = 2.33 p= 0.04), suggesting that
the increase in firing rate of NA neurons during W is due to an
increase in persistent synaptic excitatory input and/or a decrease
in persistent synaptic inhibitory input to NA neurons rather than
periodic phasic excitation of NA neurons. On the contrary, during
NREM sleep, C.V. of the spike interval was significantly greater in
orexin/ataxin-3 mice than in wildtype mice (t36 = 3.41 p= 0.002),
reflecting a relatively more irregular distribution of interspike
intervals in orexin/ataxin-3 neurons during NREM sleep.
During NREM sleep, NA neurons in orexin/ataxin-3 mice
showed significant differences in firing profile in the early time
window of NREM sleep as compared with those in wildtype mice.
In wildtype mice, NA neurons ceased firing immediately before
the onset of EEG synchronization. In contrast, in orexin/ataxin-3
mice, NA neurons continued to fire after entry into NREM sleep
(Fig. 2C, D). This remaining firing lasted at least 60 sec.
We examined the time course of the decrease in firing frequency
of NA neurons every 20 seconds from the start of NREM sleep
(Fig. 2F). In the first 20-second window, firing frequency of NA
neurons in orexin/ataxin-3 showed a tendency to be higher than
that in wildtype (orexin/ataxin-3, 0.325 Hz; wildtype, 0.136 Hz,
t33 = 2.02 p= 0.052). In the next 20-second window, firing
frequency in orexin/ataxin-3 was significantly higher than that in
Figure 1. Single unit recordings of 5-HT neurons in dorsal raphe nucleus of wildtype mice and orexin/ataxin-3 mice in different
behavioral states. A, Averaged trace of action potentials of neurons recorded from DR. 5-HT neurons displayed a broad asymmetrical biphasic
spike wave form. The first positive component had large amplitude. The descending part often exhibited a shoulder. The negative component
decayed slowly and its amplitude was much smaller than that of the positive component. B, Histological verification of recording position. Left panel,
Pontamine Sky Blue deposit indicated by an arrowhead is seen in electrode track near the DR. Right panel, Locations of recorded neurons are plotted
as black dots on diagrams of serial coronal sections in DR. The number below each section denotes distance (mm) from bregma. C, Representative
traces of 5-HT neuron spikes and EEG/EMG recordings in wildtype mice. The firing rate of this neuron increased during W, gradually decreased during
NREM sleep, and was inactive during REM sleep. States were judged by EEG and EMG recordings. D, Representative traces of 5-HT neuron spikes and
EEG/EMG recordings in orexin/ataxin-3 mice. Firing patterns across W-NREM sleep and REM sleep-W transitions were not different from those in
wildtype mice. E, Firing frequency of 5-HT neurons in wildtype mice (W, NREM, REM: n= 19, 21, 14) and orexin/ataxin-3 mice (W, NREM, REM: n = 18,
23, 14). Abbreviations: W, waking; DRC, dorsal raphe caudal part; DRD, dorsal raphe dorsal part; DRI, dorsal raphe interfascicular part; DRV, dorsal
raphe ventral part; DRVL, dorsal raphe ventrolateral part.
doi:10.1371/journal.pone.0070012.g001
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wildtype (orexin/ataxin-3, 0.154 Hz; wildtype, 0.006 Hz,
t12.16 = 2.70 p= 0.019). In the third 20 seconds after NREM sleep
onset, although there was no significant difference between
genotypes, firing continued during the later portion of NREM
sleep in orexin/ataxin-3 mice (orexin/ataxin-3, 0.075 Hz; wildtype,
0 Hz, t5 = 1.32 p= 0.36). This occasional firing was not observed
in wildtype mice. From these observations, NA neurons in orexin/
ataxin-3 mice seemed to be more excitable during NREM sleep.
We also observed periodic firing of NA neurons during REM sleep
in orexin/ataxin-3 mice, further suggesting dysregulation of NA
neurons.
Change in the firing frequency of NA neurons is known to be
correlated with vigilance level, so we examined whether the
vigilance level differed between wildtype and orexin/ataxin-3 mice
in our recording condition. EEG frequency distribution was
analyzed by power spectral analysis, Fast Fourier Transformation
(FFT), during wakefulness. The percentage of EEG power in the
delta, theta, alpha and beta frequency bands showed no significant
difference between wildtype and orexin/ataxin-3 mice (45.260.9%
vs 42.761.0%, t18 = 1.85 p= 0.08, 29.961.0% vs 32.560.9%,
t18 = 1.99 p= 0.06, 14.260.8% vs 13.960.5%, t18 = 0.41 p= 0.69,
10.760.7% vs 10.860.3%, t18 = 0.16 p= 0.87 for delta, theta,
alpha and beta frequency, respectively). This result suggests that
the vigilance level during wakefulness was not significantly
different between wildtype and orexin/ataxin-3 mice in this
recording condition.
We next examined whether the firing pattern of NA neurons at
the transition from sleep to wakefulness differed between the two
genotypes. Almost all NA neurons of both genotypes started firing
before the onset of EEG activation. This result is in good
agreement with a previous report [29]. Of a total of 15 neurons in
wildtype mice, 13 NA neurons discharged prior to, 2 at the same
time as, and 0 after the onset of W. In orexin/ataxin-3 mice, firing
showed a similar pattern; 20 of 21 discharged prior to and 1 at the
same time as the onset of W, and no neuron discharged after the
onset of W.
These results indicate that the activity profile of LC neurons
during the transition from NREM sleep to W in orexin/ataxin-3
mice was similar to that in wildtype mice.
Spontaneous IPSC Frequency of NA Neurons is
Decreased in Narcoleptic Mice
Since we found an abnormality in the firing pattern of NA
neurons in orexin/ataxin-3 mice during wakefulness and NREM
sleep, we hypothesized that alterations of inhibitory and/or
excitatory synaptic input of these neurons occurred in orexin/
ataxin-3 mice. To evaluate this hypothesis, we examined the
frequency of sIPSCs and sEPSCs in these neurons. For electro-
physiological recording, we used transgenic mice expressing GFP
exclusively in tyrosine hydroxylase (TH)-producing neurons (Th-
gfp mice). Th-gfp;orexin/ataxin-3 double transgenic (Th-gfp;orexin/
ataxin-3) mice were used as a narcolepsy model.
First, we examined basic electrophysiological characteristics of
NA neurons of orexin/ataxin-3 mice. Membrane potential, firing
frequency and membrane capacitance of noradrenergic neurons in
wildtype mice and orexin/ataxin-3 mice were 44.961.3 mV vs
44.661.2 mV, t25 = 0.25 p= 0.81, 5.1460.51 Hz vs
5.3460.38 Hz, t23 = 0.23 p= 0.78, and 62.365.8 pF vs
60.664pF, t12 = 0.21 p= 0.84, respectively. These results suggest
that the basic characteristics of NA neurons are not altered in
orexin/ataxin-3 mice.
Next, we examined spontaneous EPSCs and IPSCs (sEPSCs
and sIPSCs) in NA neurons. There was no significant difference in
frequency of sEPSCs between wildtype mice and orexin/ataxin-3
mice (wildtype, 0.7660.14Hz, n= 7; orexin/ataxin-3, 0.6260.22Hz,
n = 7, t12 = 0.52 p= 0.61) (Fig. 3A). Amplitude of sEPSCs showed
no significant difference (Fig. 3B) (wildtype: 19.661.7 pA, n= 7,
orexin/ataxin-3:16.961.7 pA, n= 7, t12 = 1.18 p= 0.26).
However, the frequency of spontaneous sIPSCs was significantly
lower in orexin/ataxin-3 mice (0.2960.08 Hz, n = 6) than in
wildtype mice (0.6260.10 Hz, n= 7, F1.11 = 4.47 p= 0.05)
(Fig. 3C). Amplitude of sIPSCs showed no significant difference
(wildtype: 17.560.9 pA, n= 7, orexin/ataxin23:17.461.7 pA,
n = 6, t11 = 0.06, p= 0.95) (Fig. 3D).
Next, we examined miniature EPSCs (mEPSCs) and miniature
IPSCs (mIPSCs) of NA neurons in orexin/ataxin-3 mice. There was
no significant difference in frequency of mEPSCs between orexin/
ataxin-3 mice and wildtype mice (wildtype: 1.3360.28 Hz, n= 6,
orexin/ataxin23:1.6460.21 Hz, n = 8, t12 = 0.91 p= 0.38) (Fig. 4A).
Amplitude of mEPSCs also showed no significant difference
(Fig. 4B) (wildtype: 21.062.5 pA, n = 6, orexin/atax-
in23:19.960.7 pA, n = 8, t12 = 0.90 p= 0.63).
However, frequency of mIPSCs was significantly lower in orexin/
ataxin-3 mice (0.4660.07 Hz, n= 8) than in wildtype mice
(0.8060.10 Hz, n= 10, F1.16 = 5.07 p= 0.04) (Fig. 4 C). Amplitude
of mIPSCs showed no significant difference (wildtype:
28.162.8 pA, n= 10, orexin/ataxin23:22.261.5 pA, n= 8,
t16 = 1.71, p = 0.11) (Fig. 4D).
Overall Density of Inhibitory Synapses in Orexin/Ataxin-3
Mice is not Altered
To decipher the neuronal mechanism by which IPSCs are
decreased in the LC of orexin/ataxin-3 mice, we examined
GABAergic and glutamatergic synapses in the LC by double
immunofluorescent staining for norepinephrine transporter (NET)
(red in Fig. 5A–F) to define the region containing NA neurons and
for neurochemical terminal markers vesicular glutamate trans-
porter (VGluT)1, VGluT2, and vesicular inhibitory amino-acid
transporter (VIAAT) (green). In both orexin/ataxin-3 mice and
wildtype littermates, VGluT1-, VGluT2-, and VIAAT-positive
Figure 2. Single unit recordings of NA neurons in LC of wildtype mice and orexin/ataxin-3 mice in different behavioral states. A,
Averaged trace of action potentials of neurons recorded from LC. NA neurons displayed a broad asymmetrical biphasic spike waveform like that of 5-
HT neurons in Fig. 1. B, Histological verification of recording position. Upper panels, Typical example of histological appearance. Pontamine Sky Blue
deposits indicated by arrowheads are seen in electrode track near LC. Right panel is high power view of rectangular region in left panel. Lower panels,
Locations of recorded neurons are plotted as black dots on diagrams of serial coronal sections in LC. C, Representative traces of NA neuron spikes and
EEG/EMG recordings in wildtype mice. NA neurons increased firing during wakefulness, almost ceased before entering NREM sleep, and completely
ceased firing during REM sleep. D, Representative traces of NA neuron spikes and EEG/EMG recordings in orexin/ataxin-3 mice. Firing continued after
the transition from W to NREM sleep. Arrows indicate the remaining firing during NREM sleep. E, Firing rates of NA LC neurons in wildtype (W, NREM,
REM: n = 9, 19, 9) mice and orexin/ataxin-3 mice (W, NREM, REM: n = 11, 19, 7). Firing rates of LC neurons in orexin/ataxin-3 mice were significantly
higher than those in wildtype during W and NREM sleep. F, Time course of decrease in firing frequency during NREM sleep. NA neurons of orexin/
ataxin-3 mice continued to fire after entry into NREM sleep, especially in the early stage of NREM sleep. Numbers on horizontal axis are time (s) after
onset of NREM sleep. At 0 to 40 seconds after the onset of NREM sleep, firing frequency was higher in orexin/ataxin-3 mice. * p,0.05.
doi:10.1371/journal.pone.0070012.g002
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terminals were present in the neuropil, and distributed around
NET-stained somata and dendrites of LC neurons.
We did not detect any obvious change in density of excitatory
and inhibitory terminals. This was confirmed by no significant
difference in the density of VGluT1-, VGluT2, and VIAAT-
immunostained terminals in the neuropil (n = 4–5 images from
each mouse, p.0.05, Fig. 5G).
These results suggest that the increase in firing frequency during
W and NREM sleep in orexin/ataxin-3 mice might be at least partly
due to decreased activity of inhibitory neurons projecting to NA
neurons, rather than a decrease in number of GABAergic synaptic
innervations to NA neurons.
Discussion
Since orexins are thought to play an important role in
regulation of monoaminergic neurons, it is reasonable to
hypothesize that orexin neuronal loss leads to alterations in
functions of monoaminergic neurons. Previous studies reported
that, in the narcoleptic dog, noradrenergic cells of the locus
coeruleus ceased discharge during cataplexy, while dorsal raphe
REM sleep-off neurons did not cease discharge during cataplexy
[28,30]. However, no report has thus far examined abnormality of
firing patterns of these neurons during the transitions of behavioral
states.
In this study, we recorded single-unit activities of 5-HT neurons
and NA neurons in the DR and LC of wildtype and narcoleptic
mice. These nuclei receive major orexinergic innervations and are
known to be involved in sleep/wakefulness regulation. We found
that the firing pattern of NA neurons was markedly altered in
narcoleptic mice, and this change might be due to functional
change of GABAergic input to these cells.
Our previous studies showed that orexin/ataxin-3 mice had
reduced mean wakefulness duration and increased number of
Figure 3. Spontaneous EPSCs and IPSCs in wildtype and orexin/ataxin-3 mice. We crossed these mice with Th-GFP mice for identification of
NA neurons. sEPSCs and sIPSCs were recorded from NA neurons in the LC under whole cell patch clamp recording at a holding potential of 260 mV.
NA neurons were identified by green fluorescence. A. Cumulative probability plots of sEPSC inter-event intervals of wildtype indicated by open circles
and orexin/ataxin-3 indicated by closed circles (n = 7, 200 ms bin). Inset in A shows mean sEPSC frequency of wildtype mice (WT) and orexin/ataxin-3
mice (Tg). B. Cumulative probability plots of sEPSC amplitude. Inset shows mean sEPSC amplitude of wildtype mice (WT) and orexin/ataxin-3 mice
(Tg). C. Cumulative probability plots of sIPSC inter-event intervals (n = 6–7), showing decrease in sIPSC frequency in orexin/ataxin-3 mice. D.
Cumulative probability plots of sIPSC amplitude. * p,0.05.
doi:10.1371/journal.pone.0070012.g003
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episodes of wakefulness in a freely moving condition during the
dark period [27]. Orexin knockout mice and orexin/ataxin-3 mice
also showed fragmentation of NREM sleep [26], which is
consistent with the nocturnal awakenings often seen human
narcolepsy. This abnormality of NREM sleep, characterized by
difficulty in maintaining consolidated NREM sleep, cannot be
simply explained by orexin deficiency, because orexin neuronal
activity ceases during NREM sleep [25]. Therefore, we hypoth-
esized that chronic alteration of orexin receptor-expressing
neurons, due to compensatory changes of these cells, might be
responsible for the instability of NREM sleep in orexin/ataxin-3
mice. To evaluate this possibility, we performed in vivo extracel-
lular recording of NA neurons and 5-HT neurons in these mice.
As compared to rats, 5-HT neurons in the DR of mice
demonstrated lower firing frequency during wakefulness, while the
firing frequency of these neurons during NREM sleep and REM
sleep exhibited a similar pattern to that in rats [22,31]. Spike form
was nearly identical to that in rats [31,32]. 5-HT neurons of both
wildtype mice and orexin/ataxin-3 mice fired rapidly during W,
decreased during NREM sleep, and ceased during REM sleep in a
similar manner (Fig. 1C, D). There was no significant difference in
the firing frequency of 5-HT neurons between wildtype mice and
orexin/ataxin-3 mice (Fig. 1E). These results suggest that chronic
deficiency of orexin neurons does not have large impact on the
firing pattern of 5-HT neurons in DR during sleep/wake states in
this experimental condition, although during NREM sleep, firing
frequency tended to be increased in orexin/ataxin-3 mice (Fig. 1E).
On the other hand, NA neurons of orexin/ataxin-3 mice showed
significantly higher firing frequency than that in wildtype mice
during W and NREM sleep (Fig. 2E). In wildtype mice, unlike 5-
HT neurons in the DR, NA neurons in the LC almost completely
ceased firing before the onset of cortical EEG synchronization
(Fig. 2C). This firing pattern is in good agreement with a previous
report [29]. However, NA neurons in orexin/ataxin-3 mice showed
residual firing after the transition to NREM sleep (Fig. 2F). Since
noradrenergic tone plays an important role in arousal, the increase
in firing of NA neurons in the LC during NREM sleep might
contribute to the instability of NREM sleep in narcolepsy and
Figure 4. Miniature EPSCs and IPSCs in wildtype and orexin/ataxin-3 mice. The frequency of mIPSCs was decreased in LC neurons of orexin/
ataxin-3 mice. A. mEPSCs were recorded by whole cell patch clamp at a holding potential of 260 mV. Cumulative probability plots of mEPSC inter-
event intervals of wildtype indicated by open circles and orexin/ataxin-3 indicated by closed circles (n = 6–8, 200 ms bin). Inset in A shows mean
mEPSC frequency of wildtype mice (WT) and orexin/ataxin-3 mice (Tg). B. Cumulative probability plots of mEPSC amplitude. Inset shows mean mEPSC
amplitude of wildtype mice (WT) and orexin/ataxin-3 mice (Tg). C. Cumulative probability plots of mIPSC inter-event intervals (n = 8–10), showing
decrease in mIPSC frequency in orexin/ataxin-3 mice. D. Cumulative probability plots of mIPSC amplitude. * p,0.05.
doi:10.1371/journal.pone.0070012.g004
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might be related to the frequent nocturnal awakenings in
narcoleptic patients.
Moreover, the firing rate of NA neurons during W was also
increased in orexin/ataxin-3 mice (Fig. 2E). These observations
suggest that an increased firing rate of NA neurons, causing
imbalance between NA neurons and 5-HT neurons, might
possibly be related to behavioral arrests seen in orexin/ataxin-3
mice [27]. Conversely, the change in firing pattern of NA neurons
at the transition from sleep to wakefulness in orexin/ataxin-3 mice
was comparable to that in wildtype mice. These neurons increase
firing before the end of NREM sleep and thereby herald the return
of the waking state by several seconds. This suggests that the
increase in firing rate of NA neurons upon wakening is not
dependent on the orexin system.
In addition, we found that the frequencies of sIPSCs and
mIPSCs of NA neurons are significantly decreased in orexin/ataxin-
3 mice (Figs. 3, 4). However, we could not detect a histological
change of synapses in the LC (Fig. 5). Therefore, functional, rather
than structural changes of synapses might occur in orexin/ataxin-3
mice.
The inactivation of NA neurons during sleep is thought to be
due to tonic GABAergic inhibition. Moreover, during W, NA
neurons are under GABAergic inhibitory tone [33]. It was recently
proposed that their inactivation during REM sleep is due to tonic
GABAergic inhibition arising from neurons located in the dorsal
paragigantocellular reticular nucleus (DPGi) [34] and ventrolateral
PAG (vlPAG) [35]. This GABAergic inhibition is thought to
increase progressively during NREM sleep and REM sleep. Our
present study suggests this GABAergic input to NA neurons might
be altered in narcoleptic mice. Alternatively, it is possible that
input from local GABAergic neurons is decreased, because there
are OX1R- and OX2R-positive GABAergic interneurons in and
around the LC [18].
The molecular mechanisms underlying the changes in GA-
BAergic input to orexin neurons should be addressed in future
studies. The reduced GABAergic input might result from
compensatory changes of GABAergic input, with reduced net
excitation of NA neurons due to loss of orexin neurons. These
compensatory processes might explain why narcoleptics show an




All experimental procedures involving animals were approved
by the Kanazawa University Animal Care and Use Committee
and were conducted in accordance with NIH guidelines. All efforts
were made to minimize animal suffering and discomfort and to
reduce the number of animals used. Extracellular recordings were
performed on male orexin/ataxin-3 hemizygous transgenic mice
[27] and their wildtype littermates as control. Mice with both
Figure 5. Expressions of norepinephrine transporter (red) and GABAergic/glutamatergic terminal markers (green) in LC of wildtype
mice (A–C) and orexin/ataxin-3 (D–F) mice. A, D, VGluT1; B, E, VGluT2; C, F, VIAAT. Each of the neurochemically-identified terminals is distributed
in the neuropil around NET-stained perikarya and dendritic processes of LC neurons. G. Density of VGluT1- (left), VGluT2- (middle), and VIAAT-labeled
(right) terminals per 1 mm2 of neuropil area. The total measured area was 55,245 and 50,018 mm2 for VGluT1, 43,658 and 49,415 mm2 for VGluT2, and
67,799 and 54,575 mm2 for VIAAT in wildtype and orexin/ataxin-3 mice, respectively. Scale bar, 20 mm.
doi:10.1371/journal.pone.0070012.g005
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genotypes (30–35 g body weight, 8–12 months old) were crossed to
(with) C57BL/6J mice at least seven times. Tyrosine hydroxylase-
GFP (Th-gfp) mice [36], in which green fluorescent protein in the
tyrosine gene is specifically expressed in tyrosine hydoroxylase-
expressing cells, were used in patch clamp recordings. Patch-clamp
recordings were performed on orexin/ataxin-3 and Th-gfp hemizy-
gous double transgenic (Th-gfp;orexin/ataxin-3) mice and Th-gfp
hemizygous transgenic mice as controls. Mice were maintained
under a strict 12 hour light:dark cycle (light on at 8:45 a.m., off at
8:45 p.m.) in a temperature- (22uC) and humidity-controlled room
and fed ad libitum.
Drugs
6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX), GABA, gluta-
mate, DL-2-amino-5-phosphono-pentanoic acid (AP-5) (Sigma, St.
Louis, MO, USA), and tetrodotoxin (TTX) (Wako, Osaka, Japan)
were dissolved in physiological solution and applied by bath
application. Picrotoxin was dissolved in ethanol and applied by
bath application.
Extracellular Recording
Neuronal recording was performed on mice in an unanesthe-
tized, head-restrained condition. Mice underwent operation under
pentobarbital anesthesia (50 mg/kg i.p.) according to a procedure
described previously [37,38]. In brief, electrodes for recording
electroencephalographic (EEG) and neck electromyographic
(EMG) activity were implanted, and a U-shaped plastic plate
was attached to the skull using dental acrylic cement so that the
mouse’s head was fixed to the stereotaxic frame. After a 7-day
recovery period, they were placed in a plastic box, and the U-
shaped plate on their head was fixed to a stereotaxic frame. After
habituation for at least five days, recording was performed from
13:00 to 18:00.
Single neuronal activity was recorded extracellularly through a
glass pipette microelectrode filled with 0.5 M sodium acetate
solution containing 2% Pontamine Sky Blue. The neuronal
activity was amplified, and filtered with a high-pass cut-off
frequency of 10 Hz and a low-pass cut-off frequency of 10 kHz.
The activity was digitized at a sampling rate of 10 kHz with a
CED 1410 data processor (Cambridge Electronic Design). 5-HT
neurons in the dorsal raphe (DR) and NA neurons in the LC were
discriminated from others by their longer-duration action poten-
tials (time from onset of positive component to bottom of negative
component .0.9 ms), a shoulder on the falling phase (Figs. 1A,
2A), and the firing pattern during sleep-wakefulness cycles: tonic
firing during wakefulness, decrease in frequency during slow wave
sleep, and complete cessation of firing during REM sleep [5,29].
To mark the locations of neurons from which we recorded,
Pontamine Sky Blue was injected from the recording electrode by
passing a negative current (10–15 mA for 6 min) to one or two
recording sites in each electrode track. After the experiment, the
animals were deeply anesthetized with pentobarbital and perfused
through the left cardiac ventricle with 20 ml PBS followed by
20 ml of 4% paraformaldehyde in 0.1 M phosphate buffer. The
brain was then removed, postfixed in the same fixative for 24 hr,
and sectioned in the coronal plane at a thickness of 40 mm. The
sections were then stained with Neutral Red. Nicotinamide
adenine diphosphate (NADPH)-diaphorase histochemical staining
was used to visualize especially the serotonergic neurons in the
DR. Brains and blood samples from some mice were subjected to
measurements of CRH and corticosterone levels after the
recording experiments.
EEG and EMG Recording
Male mice were anesthetized and chronically implanted for
continuous monitoring of EEG/EMG as described previously
(Chemelli et al., 1999). Animals were housed with a 12 hr light/
dark cycle and allowed to habituate to recording conditions for 1
week. Four male transgenic mice and three matched wild-type
littermates were subjected to recording concurrently. EEG/EMG
signals were amplified and filtered (EEG: 0.3–100 Hz, EMG: 30–
300 Hz) before being digitized at a sampling rate of 250 Hz, and
displayed on a polygraph system. EEG/EMG records were
visually scored into 4-s epochs of wakefulness, REM, and non-
REM sleep according to standard criteria of rodent sleep [39].
Vigilance states of mice were divided into wakefulness (W), non-
rapid eye movement sleep (NREM sleep) and rapid eye movement
sleep (REM sleep). Quiet wakefulness (qW) was defined as the
period of wakefulness with no or very low locomotor activity and
whisker movement, which is often observed before entering
NREM sleep.
Brain Slice Preparation
Th-gfp;orexin/ataxin-3 mice and Th-gfp hemizygous transgenic
mice (6–8 weeks old) were anesthetized with isoflurane (Abbott,
Osaka, Japan). The mice were decapitated under deep anesthesia.
Brains were isolated in ice-cold cutting solution consisting of (mM):
280 sucrose, 2 KCl, 10 HEPES, 0.5 CaCl2, 10 MgCl2, 10 glucose,
pH 7.4, bubbled with 100% O2. Brains were cut coronally into
300-mm slices with a microtome (VTA-1000S, Leica, Germany).
Slices containing the LC were transferred for at least 1 h into an
incubation chamber at room temperature (RT; 24–26uC) filled
with extracellular solution containing (mM): 135 NaCl, 5 KCl,
1 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose, pH 7.4.
Patch Clamp Recording
Th-gfp mice and Th-gfp;orexin/ataxin-3 double transgenic mice
were used for whole cell patch clamp recordings. The slices were
transferred to a recording chamber (RC-27L, Warner Instrument
Corp., CT, USA) at 32uC on a fluorescence microscope stage
(BX51WI, Olympus, Tokyo, Japan). EGFP is expressed in tyrosine
hydroxylase neurons in the Th-gfp mouse brain, and neurons that
showed GFP fluorescence were used for patch clamp recordings
[36,40]. The fluorescence microscope was equipped with an
infrared camera (C-3077, Hamamatsu Photonics, Hamamatsu,
Japan) for infrared differential interference contrast (IR-DIC)
imaging and a CCD camera (JK-TU53H, Olympus) for fluores-
cent imaging. Recordings were carried out with an Axopatch 200B
amplifier (Axon Instruments, Foster City, CA) using a borosilicate
pipette (GC150-10, Harvard Apparatus, Holliston, MA) prepared
using a micropipette puller (P-97, Sutter Instruments, Pangbourne,
UK) and filled with intracellular solution consisting of (mM):
125 K-gluconate, 5 KCl, 1 MgCl2, 10 HEPES, 1.1 EGTA-Na3,
5 MgATP, 0.5 Na2GTP, pH7.3 with KOH. Osmolarity of the
solution was checked with a vapor pressure osmometer (model
5520, Wescor, Logan, UT). The osmolarity of the internal and
external solutions was 280–290 and 320–330 mOsm/l, respec-
tively. The liquid junction potential of the patch pipette and
perfused extracellular solution was estimated to be 216.2 mV and
was applied to the data. The recording pipette was under positive
pressure while it was advanced toward an individual cell in the
slice. A tight seal of 0.5–1.0 GV was made by applying negative
pressure. The membrane patch was then ruptured by suction. The
series resistance during recording was 10–25 MV and was
compensated. The reference electrode was an Ag-AgCl pellet
immersed in the bath solution. During recordings, cells were
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superfused with extracellular solution at a rate of 1.0–2.0 ml/min
using a peristaltic pump (K.T. Lab, Japan).
Spontaneous excitatory postsynaptic currents (sEPSCs), sponta-
neous inhibitory postsynaptic currents (sIPSCs), miniature excit-
atory postsynaptic currents (mEPSCs) and miniature inhibitory
postsynaptic currents (mIPSCs) were recorded in NA neurons
under whole cell voltage clamp mode at a holding potential of
260 mV. sEPSCs were recorded using KCl-based pipette solution
consisting of (mM): 145 KCl, 1 MgCl2, 10 HEPES, 1.1 EGTA-
Na3, 2 MgATP, 0.5 Na2GTP, pH7.3 with KOH and the sodium
channel blocker QX-314 (1 mM) to inhibit action potentials in the
recording neuron and in the presence of picrotoxin (100 mM) in
the extracellular solution. sIPSCs were recorded using KCl-based
pipette solution containing QX-314 (1 mM) in the presence of AP-
5 (50 mM) and CNQX (20 mM) in the extracellular solution.
mEPSCs were recorded using KCl-based pipette solution in the
presence of picrotoxin (100 mM) and tetrodotoxin (1 mM) in
physiological solution consisting of (mM): 125 NaCl, 2.5 KCl,
1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2, 1 MgSO4, 11 glucose,
bubbled with 95% O2 and 5% CO2. mIPSCs were recorded using
KCl-based pipette solution in the presence of AP-5 (50 mM),
CNQX (20 mM) and tetrodotoxin (1 mM) in physiological
solution. The frequencies of sEPSCs, sIPSCs, mEPSCs and
mIPSCs were measured using Minianalysis software; only those
events with amplitude .10 pA were used. Frequency and
amplitude were presented as the mean of 200 sec duration.
Immunohistochemistry
Mice were fixed transcardially with 4% paraformaldehyde in
0.1 M sodium phosphate buffer (pH 7.2, PB) followed by 4 hr
postfixation of excised brains at 4uC. Paraffin sections through the
LC were incubated with 10% normal donkey serum for 20 min, a
mixture of primary antibodies overnight (1 mg/ml for each), and a
mixture of Alexa Fluor 488-conjugated (Invitrogen, Carlsbad, CA)
and Cy3-labeled (Jackson ImmunoResearch, West Grove, PA)
secondary antibodies (1:200) for 2 hr. As primary antibodies, we
used guinea pig or goat anti-plasmalemmal epinephrine trans-
porter (NET) [41], rabbit anti-type 1 and 2 vesicular glutamate
transporters (VGluT1 and VGluT2) [42], and rabbit anti-vesicular
inhibitory amino acid transporter (VIAAT) [43] antibodies.
Images were taken with a laser scanning microscope (FV1000,
Olympus, Tokyo, Japan) equipped with a HeNe/Ar laser system.
To avoid bleed-through into adjacent detection channels, Alexa
488 and Cy3 were excited sequentially using the 488 nm and
543 nm excitation laser lines, respectively, and emissions were
collected using a spectral detection system configured with a
galvanometer diffraction grating in combination with a variable
slit for high-resolution wavelength separation. Images were
acquired using a PlanApoN (606/1.42, oil immersion) objective
lens (Olympus) with an appropriated pinhole to obtain one Airy
unit for 496–508 nm emission wavelengths (optical section
thickness, 1.0 mm). Images were captured with confocal software
(FV10-ASW, ver.1.7, Olympus), and digitized at 12 bit resolution
into an array of 6406640 pixels (pixel size, 0.1 mm). To compare
the density of immunostained nerve terminals in the neuropil of
the LC, we measured the number of immunostained terminals and
the area of neuropil, excluding neuronal somata and capillaries,
using MetaMorph software (Molecular Devices, Downingtown,
PA). Genotypic differences in terminal density were statistically
evaluated by Student’s t-test.
Tissue and Blood Collection and Serum Analysis
To determine the effect of a restrained condition on serum
corticosterone level, blood from wild type and orexin/ataxin-3 mice
was collected under deep anesthesia. About 400–500 ml blood was
collected from the heart. Blood was incubated at 37uC for 30 min,
then at 4uC for 12 h followed by centrifugation at 4uC (1200 g,
30 min) to collect serum. The brain was carefully removed and the
hypothalamus collected. Samples of the brain and serum were
stored at 280uC until measurement. The level of serum
corticosterone was determined by a solid-phase radioimmunoas-
say.
CRF mRNA
Total RNA was isolated from the hypothalamus of restrained
mice using a RNeasy lipid tissue minikit (Qiagen) according to the
manufacturer’s instructions. cDNA was generated from 500 ng of
total RNA using Superscript III First-Strand Synthesis Supermix
for qRT-PCR (Invitrogen). qPCRs was performed in a Light-
CyclerH 480 II (Roche Applied Science) with an appropriate
Universal Probe (Roche). mRNA expression of the CRF and b-
actin genes was measured using LightCyclerH 480 software version
1.5.0 (Roche Applied Science). mRNA quantification of each
target gene under each condition was normalized to b-actin.
Statistical Analysis
Data were analyzed by unpaired Student’s t-test using the Stat
View 5.0 software package for Macintosh (Abacus Concepts,
Berkeley, CA, USA). Data of cumulative probability plots of EPSC
and IPSC were analyzed by repeated measures ANOVA.
Probability (p)-values less than 0.05 were considered statistically
significant.
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